The Latest

NHS England Doubles Places on IMPACT PrEP Study to 26,000

Although the move means that more Britons might be able to access free PrEP, this study is also controversial for being seen as a way to delay full government approval.

By Simon Collins for HIV i-Base

More Than 30 Years Later, the UK Government Opens Inquiry Into Blood Contaminated With HIV and Hepatitis C

On Sept. 24, the first widespread inquiry into how thousands of people in the United Kingdom received contaminated blood in the 1970s and 1980s began with a preliminary hearing and a commemoration event dedicated to the victims.

By Martha Kempner

Drop in HIV Incidence in UK Gay Men: Frequent Testing, Early ART and PrEP

Exciting data on reduced HIV incidence among gay men attending five London clinics.

By Simon Collins for HIV i-Base

Four London Clinics Report Dramatic Drops in HIV Incidence in Gay Men: PrEP, Early Testing and Early ART Are Likely to Be Key

At the end of December, several leading London sexual health clinics used social media to report significant drops in number of gay men who were diagnosed HIV positive during 2016.

By Simon Collins for HIV i-Base

Antiretroviral Therapy Not Linked to Condomless Sex in Large UK Study

Taking antiretroviral therapy did not raise the likelihood of sex without condoms in a cross-sectional study of 3178 men and women in the United Kingdom.

By Mark Mascolini

Increasing Demand for Community Treatment Information Services

A review of the treatment information services provided by HIV i-Base and their use over the last year.

By Gareth Hardy for HIV i-Base

NHS England Pulls Proposed Timeline for PrEP: Perpetuates HIV Health Crisis in Gay Men and Trans People

Simon Collins of HIV i-Base reacts scathingly to England's apparent decision to "block access to the most effective new option for protecting people at highest risk from catching HIV."

By Simon Collins for HIV i-Base

Savings to the NHS Predicted From Switching to Generic Antiretrovirals

If everyone on HIV treatment in the UK switched from patented originator antiretrovirals to generics, there is the potential to save £1.25 billion in NHS drug costs over the next five years (2015-2019), according to modelling data presented at the 20...

By Polly Clayden for HIV i-Base

U.K. Updates PEP Guidelines: Raltegravir Replaces PIs and No Indication if Positive Partner Has an Undetectable Viral Load

The United Kingdom Chief Medical Officers' Expert Advisory Group on AIDS (EAGA) has issued new guidance for post exposure prophylaxis (PEP) that includes using raltegravir (Isentress) rather than a boosted protease inhibitor.

By Simon Collins for HIV i-Base

Scotland: HIV Treatment to Be Free for Scots

This article was reported by the Herald Scotland.

The Herald Scotland reported that the Scottish Government has decided to make HIV treatment free to everyone in Scotland, regardless of their residency status. The policy change aligns Scotland with ...

By CDC National Prevention Information Network